Veterinary Research Forum
Vet Res Forum

Effects of different durations of high-intensity interval training or continuous training with/without metformin on lipid profile and malondialdehyde level in a rat model of polycystic ovary syndrome

Document Type : Original Article

Authors

Fatemeh Zolfaghari 1
Akbar Nouri Habashi 1
Safiyeh Aghazadeh 2

1 Department of Exercise Physiology and Corrective Exercises, Faculty of Sport Sciences, Urmia University, Urmia, Iran

2 Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

https://doi.org/10.30466/vrf.2025.2050200.4623
Abstract
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder. Exercise is one of the interventions that leads to PCOS improvement. This study aimed to investigate the potential of different durations of high-intensity interval training (HIIT) or continuous training (CT) with/ without metformin (MET) in a rat model of PCOS. For this purpose, the rats were randomly placed in seven groups, including control, PCOS, PCOS + CT, PCOS + HIIT, PCOS + MET, PCOS + MET + CT, and PCOS + MET + HIIT. The PCOS was induced by a single intra-muscular injection of 2.00 mg kg-1 estradiol valerate. The concentration of lipid indices showed that serum cholesterol and low-density lipoprotein decreased, and high-density lipoprotein increased with 8 and 12 weeks of exercise training in PCOS + CT, PCOS + HIIT, PCOS + MET + CT, and PCOS + MET + HIIT groups compared to the PCOS group, but no significant difference was found between groups. Triglyceride level decreased in treated groups with 12 weeks of exercise compared to the PCOS group, and there was no significant difference between the treated groups. Finally, serum malondialdehyde level decreased in groups received exercise intervention alone or combined with MET compared to the PCOS group. These findings revealed that HIIT and CT with longer periods with/without MET can lead to improvement of lipid profile and malondialdehyde level of PCOS patients.

Keywords

Continuous training
High-intensity interval training
Lipid profile
Malondialdehyde
Polycystic ovary syndrome
Subjects
1.     March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25(2): 544-551.
2.     Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016; 106(1): 6-15.
3.     Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81(1): 19-25.
4.     Palomba S, Santagni S, Falbo A, et al. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health 2015: 7: 745-763.
5.     Riestenberg C, Jagasia A, Markovic D, et al. Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab 2022; 107(2): 575-585.
6.     Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, et al. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrin Met 2007; 18(7): 280-285.
7.     Yeon Lee J, Baw CK, Gupta S, et al. Role of oxidative stress in polycystic ovary syndrome. Curr Womens Health Rev 2010; 6(2): 96-107.
8.     Desai V, Prasad NR, Manohar SM, et al. Oxidative stress in non-obese women with polycystic ovarian syndrome. J Clin Diagn Res 2014; 8(7): CC01-CC03.
9.     Mohan SK, Priya VV. Lipid peroxidation, glutathione, ascorbic acid, vitamin E, antioxidant enzyme and serum homocysteine status in patients with polycystic ovary syndrome. J Bio Med 2009; 1(3): 44-49.
10. Rajaei S. Antioxidant effect of genistein on ovarian tissue morphology, oxidant and antioxidant activity in rats with induced polycystic ovary syndrome. Int J Reprod Biomed 2019; 17(1): 11-22.
11. Ndeingang EC, Defo Deeh PB, Watcho P, et al. Phyllanthus muellerianus (Euphorbiaceae) restores ovarian functions in letrozole‐induced polycystic ovarian syndrome in rats. Evid Based Complement Alternat Med 2019: 2965821. doi: 10.1155/2019/ 2965821.
12. Gu Y, Zhou G, Zhou F, et al. Life modifications and PCOS: old story but new tales. Front Endocrinol 2022; 13: 808898. doi: 10.3389/fendo.2022.808898.
13. Shele G, Genkil J, Speelman D. A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome. J Funct Morphol Kinesiol 2020; 5(2): 35. doi: 10.3390/jfmk5020035.
14. Colombo GE, Bouzo XD, Patten RK, et al. Comparison of selected exercise training modalities in the management of PCOS: a systematic review and meta-analysis to inform evidence-based guidelines. JSAMS Plus 2023; 2: 100024.
15. Viana RB, Naves JP, Coswig VS, et al. Is interval training the magic bullet for fat loss? A systematic review and meta-analysis comparing moderate-intensity continuous training with high-intensity interval training (HIIT). Br J Sports Med 2019; 53(10): 655-664.
16. Benham JL, Yamamoto JM, Friedenreich CM, et al. Role of exercise training in polycystic ovary syndrome: a systematic review and meta‐analysis. Clin Obes 2018; 8(4): 275-284.
17. Ribeiro VB, Kogure GS, Lopes IP, et al. Effects of continuous and intermittent aerobic physical training on hormonal and metabolic profile, and body composition in women with polycystic ovary syndrome: A randomized controlled trial. J Clin Endocr 2020; 93(2): 173-186.
18. Almenning I, Rieber-Mohn A, Lundgren KM, et al. Effects of high intensity interval training and strength training on metabolic, cardiovascular and hormonal outcomes in women with polycystic ovary syndrome: a pilot study. Plos One 2015; 10(9): e0138793.
19. Turan V, Mutlu EK, Solmaz U, et al. Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study. J Phys Ther Sci 2015; 27(7): 2293-2297.
20. Lőrincz CE, Börzsei D, Hoffmann A, et al. Mechanisms and target parameters in relation to polycystic ovary syndrome and physical exercise: focus on the master triad of hormonal changes, oxidative stress, and inflammation. Biomedicines 2024; 12(3): 560. doi: 10.3390/biomedicines12030560
21. Wu X, Wu H, Sun W, et al. Improvement of anti-Müllerian hormone and oxidative stress through regular exercise in Chinese women with polycystic ovary syndrome. Hormones 2021; 20(2): 339-345.
22. Macut D, Bjekić-Macut J, Rahelić D, et al. Insulin and the polycystic ovary syndrome. Diabetes Res Clin Pr 2017; 130: 163-170.
23. Ji X, Chen J, Xu P, et al. Effect of probiotics combined with metformin on improvement of menstrual and metabolic patterns in women with polycystic ovary syndrome: a randomized clinical trial. J Gynaecol Endocrinol 2022; 38(10): 856-860.
24. Swathi A, Vijayalakshmi, Reddy IY. Effect of Metformin therapy on lipid profile in obese and non-obese women with polycystic ovarian syndrome (PCOS). Biomedicines 2022; 42(1): 134-137.
25. Song Y, Wang H, Zhu Z, et al. Effects of metformin and exercise in polycystic ovary syndrome: systematic review and meta-analysis. Horm Metab Res 2021; 53(11): 738-745.
26. Care I. of LAR (US). C on, animals U of L. Guide for the care and use of laboratory animals. US Department of Health and Human Services. Public Health Service, National 1986.
27. Aghaie F, Khazali H, Hedayati M, et al. The effects of moderate treadmill and running wheel exercises on oxidative stress in female rats with steroid-induced polycystic ovaries. Physiol Pharmacol 2016; 20(4): 277-286.
28. Brawer JR, Munoz M, Farookhi R. Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat. Biol Reprod 1986; 35(3): 647-655.
29. Linares R, Hernández D, Morán C, et al. Unilateral or bilateral vagotomy induces ovulation in both ovaries of rats with polycystic ovarian syndrome. Reprod biol endocrinol 2013; 11(1): 68.
30. Tao X, Cai L, Chen L, et al. Effects of metformin and Exenatide on insulin resistance and AMPKα-SIRT1 molecular pathway in PCOS rats. J Ovarian Res 2019; 12(1): 86.
31. Lee JC, Pak SC, Lee SH, et al. The effect of herbal medicine on nerve growth factor in estradiol valerate-induced polycystic ovaries in rats. Am J Chin Med 2003; 31(06): 885-895.
32. Sabouri M, Norouzi J, Zarei Y, et al. Comparing High‐Intensity Interval Training (HIIT) and Continuous Training on Apelin, APJ, NO, and Cardiotrophin‐1 in Cardiac Tissue of Diabetic Rats. J Diabetes Res 2020; 1: 1472514.
33. Bedford TG, Tipton CM, Wilson NC, et al. Maximum oxygen consumption of rats and its changes with various experimental procedures. J Appl Physiol 1979; 47(6): 1278-1283.
34. Leandro CG, Levada AC, Hirabara SM, et al. Aprogram of moderate physical training for wistar rats based on maximal oxygen consumption. J Strength Cond Res 2007; 21(3): 751-756.
35. Wellington D, Mikaelian I, Singer L. Comparison of ketamine–xylazine and ketamine–dexmedetomidine anesthesia and intraperitoneal tolerance in rats. J Am Assoc Lab Anim Sci 2013; 52(4): 481-487.
36. Hwang CL, Wu YT, Chou CH. Effect of aerobic interval training on exercise capacity and metabolic risk factors in people with cardiometabolic disorders: a meta-ana-lysis. J Cardiopulm Rehabil Prev 2011; 31(6): 378-385.
37. Gibala MJ, McGee SL. Metabolic adaptations to short-term high-intensity interval training: a little pain for a lot of gain? Exerc Sport Sci Rev 2008; 36(2): 58-63.
38. MacInnis MJ, Gibala MJ. Physiological adaptations to interval training and the role of exercise intensity. Physiol J 2017; 595(9): 2915-2930.
39. Louzada-Júnior A, da-Silva JM, da-Silva VF, et al. El Entrenamiento Multimodal es más Eficiente que el Entrenamiento Continuo Moderado para el Manejo de la Composición Corporal, El Perfil de Lípidos y el Metabolismo de la Glucosa en Adultos Mayores Diabéticos. Int J Morphol 2020; 38(2): 392-399.
40. Bruseghini P, Calabria E, Tam E, et al. Effects of eight weeks of aerobic interval training and of isoinertial resistance training on risk factors of cardiometabolic diseases and exercise capacity in healthy elderly subjects. Oncotarget 2015; 6(19): 16998.
41. Muscella A, Stefàno E, Lunetti P, et al. The regulation of fat metabolism during aerobic exercise. Biomolecules. 2020; 10(12): 1699.
42. Cao SF, Hu WL, Wu MM, et al. Effects of exercise intervention on preventing letrozole-exposed rats from polycystic ovary syndrome. Reprod Sci 2017; 24(3): 456-462.
43. Orio F, Giallauria F, Palomba S, et al. Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women. J Clin Endocr 2008; 68(6): 976-981.
44. Maughan RJ, Gleeson M, Greenhaff PL. Biochemistry of exercise and training. 4th ed. England: Oxford University Press 1997.
45. Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome—challenges and opportunities for treatment. Nat Rev Endocrinol 2021; 17(9): 521-533.
46. Kuşçu NK, Var A. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2009; 88(5): 612-617.
47. Lazúrová I, Lazúrová Z, Figurová J, et al. Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome. Physiol Res 2019; 68(3): 457-465.
Veterinary Research Forum
Volume 17, Issue 2
February 2026
Pages 111-118

  • Receive Date 29 January 2025
  • Accept Date 05 February 2025

Home

Guide for Authors

Submit Manuscript

Reviewers

Contact Us